Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endoplasmic reticulum stress-induced apoptotic pathway is a conserved cellular mechanism activated in response to prolonged or unresolvable ER stress, typically triggered by misfolded protein accumulation, calcium dysregulation, oxidative stress, or energy imbalance[1][2][3]. The unfolded protein response (UPR) initially aims to restore homeostasis by halting protein translation, increasing chaperone expression, and enhancing degradation of misfolded proteins (ERAD). If stress persists, signaling switches to pro-apoptotic outputs through molecules such as CHOP/GADD153 (inducing pro-apoptotic genes and downregulating anti-apoptotic BCL2 family members), JNK (facilitating mitochondrial apoptosis), and caspases (execution phase)[1][2][3][4]. This switch is central to pathophysiology in many diseases marked by chronic cell stress, such as neurodegeneration, metabolic disorders, and cancer.
Inhibition or activation of UPR sensors (PERK, IRE1, ATF6), modulation of downstream effectors (CHOP, JNK, caspases), use of chemical chaperones to alleviate protein misfolding, antioxidants to reduce ER-induced oxidative stress, direct proteostasis modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum stress-induced apoptotic pathway.